Company Description
Cancer patients will hopefully get a helpful shot in the arm thanks to Abraxis BioScience. Having spun off its generic injectable drug business, the...
Key Abraxis BioScience Financials
| Company Type | Public - NASDAQ (GS): ABII Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $333.7 |
| 2006 Employees | 1,864 |
More Abraxis BioScience Financials (11 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Abraxis BioScience's competition across multiple industries
Top Abraxis BioScience Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Abraxis BioScience Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Patrick Soon-Shiong | Network | E-mail |
| EVP Corporate Development | Bruce J. Wendel | Network | E-mail |
| VP, Marketing | Deena Reyes | Network | E-mail |
More Abraxis BioScience Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Abraxis BioScience News
- TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS [PCT Biblio Info] (01 Jul 2008 13:17:00 EDT)
- Abraxis BioScience Appoints David O'Toole as Chief Financial Officer [Health & Medicine Week] (09 Jun 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.